Patients can use the EU-CTR to find clinical trials that they may be eligible to participate in, offering them access to potentially life-saving treatments that are not yet widely available. The register also helps patients stay informed about the latest advances in cancer treatment and therapies, empowering them to make better-informed decisions about their care. Moreover, by participating in clinical trials, patients contribute to the advancement of cancer research and the development of new treatments.